{
    "Trade/Device Name(s)": [
        "AESKULISA dsDNA G",
        "AESKULISA\u00aedsDNA-G"
    ],
    "Submitter Information": "Aesku Diagnostics",
    "510(k) Number": "K081251",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSW"
    ],
    "Summary Letter Date": "May 1, 2008",
    "Summary Letter Received Date": "May 2, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear antibody immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG antibodies against double stranded DNA (dsDNA)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay"
    ],
    "Methodologies": [
        "Solid phase enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for AESKULISA dsDNA G enzyme immunoassay for IgG antibodies against dsDNA in human serum",
    "Indications for Use Summary": "Quantitative and qualitative detection of IgG antibodies against dsDNA in human serum to aid in diagnosis of systemic lupus erythematosus (SLE), used in conjunction with other serological tests and clinical findings",
    "fda_folder": "Immunology"
}